<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="tr" xml:lang="tr"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.7.32">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Mide kanseri (Adenokanser) â€“ Mide Kanseri</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
</style>


<script src="../../../site_libs/quarto-nav/quarto-nav.js"></script>
<script src="../../../site_libs/quarto-nav/headroom.min.js"></script>
<script src="../../../site_libs/clipboard/clipboard.min.js"></script>
<script src="../../../site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="../../../site_libs/quarto-search/fuse.min.js"></script>
<script src="../../../site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="../../../">
<link href="../../../assets/images/biyikli.png" rel="icon" type="image/png">
<script src="../../../site_libs/quarto-html/quarto.js" type="module"></script>
<script src="../../../site_libs/quarto-html/tabsets/tabsets.js" type="module"></script>
<script src="../../../site_libs/quarto-html/popper.min.js"></script>
<script src="../../../site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="../../../site_libs/quarto-html/anchor.min.js"></script>
<link href="../../../site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="../../../site_libs/quarto-html/quarto-syntax-highlighting-37eea08aefeeee20ff55810ff984fec1.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="../../../site_libs/bootstrap/bootstrap.min.js"></script>
<link href="../../../site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="../../../site_libs/bootstrap/bootstrap-c1fac2584b48ed01fb6e278e36375074.min.css" rel="stylesheet" append-hash="true" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 50,
  "keyboard-shortcut": [
    "f",
    "/",
    "s"
  ],
  "show-item-context": false,
  "language": {
    "search-no-results-text": "SonuÃ§ yok",
    "search-matching-documents-text": "eÅŸleÅŸen belgeler",
    "search-copy-link-title": "Aramak iÃ§in baÄŸlantÄ±yÄ± kopyalayÄ±n",
    "search-hide-matches-text": "Ek eÅŸleÅŸmeleri gizle",
    "search-more-match-text": "bu belgede bir tane daha eÅŸleÅŸme",
    "search-more-matches-text": "bu belgede daha fazla eÅŸleÅŸme",
    "search-clear-button-title": "Temizle",
    "search-text-placeholder": "",
    "search-detached-cancel-button-title": "Ä°ptal et",
    "search-submit-button-title": "GÃ¶nder",
    "search-label": "Ara"
  }
}</script>
<script async="" src="https://www.googletagmanager.com/gtag/js?id=G-RT0X40FTN3"></script>

<script type="text/javascript">

window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'G-RT0X40FTN3', { 'anonymize_ip': true});
</script>
<style>html{ scroll-behavior: smooth; }</style>


<link rel="stylesheet" href="../../../assets/css/styles.css">
</head>

<body class="nav-fixed fullcontent quarto-light">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top quarto-banner">
    <nav class="navbar navbar-expand-lg " data-bs-theme="dark">
      <div class="navbar-container container-fluid">
      <div class="navbar-brand-container mx-auto">
    <a class="navbar-brand" href="../../../index.html">
    <span class="navbar-title">Mide Kanseri</span>
    </a>
  </div>
            <div id="quarto-search" class="" title="Ara"></div>
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" role="menu" aria-expanded="false" aria-label="Gezinmeyi deÄŸiÅŸtir" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
  <span class="navbar-toggler-icon"></span>
</button>
          <div class="collapse navbar-collapse" id="navbarCollapse">
            <ul class="navbar-nav navbar-nav-scroll me-auto">
  <li class="nav-item">
    <a class="nav-link" href="../../../index.html"> 
<span class="menu-text">Ana Sayfa</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="../../../statik/hastalar/rehber/index.html"> 
<span class="menu-text">Hasta rehberi</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="../../../statik/iletisim/index.html"> 
<span class="menu-text">Ä°letiÅŸim</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="../../../statik/belgeler/index.html"> 
<span class="menu-text">Belgeler</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="../../../statik/about/index.html"> 
<span class="menu-text">Biz Kimiz</span></a>
  </li>  
</ul>
            <ul class="navbar-nav navbar-nav-scroll ms-auto">
  <li class="nav-item dropdown ">
    <a class="nav-link dropdown-toggle" href="#" id="nav-menu-hastalÄ±klar" role="link" data-bs-toggle="dropdown" aria-expanded="false">
 <span class="menu-text">HastalÄ±klar</span>
    </a>
    <ul class="dropdown-menu dropdown-menu-end" aria-labelledby="nav-menu-hastalÄ±klar">    
        <li>
    <a class="dropdown-item" href="../../../statik/hastalar/adenoca/index.html">
 <span class="dropdown-text">Mide kanseri (Adenokanser)</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../../../statik/hastalar/gist/index.html">
 <span class="dropdown-text">GIST</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../../../statik/hastalar/net/index.html">
 <span class="dropdown-text">NÃ¶roendokrin TÃ¼mÃ¶r</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../../../statik/hastalar/lenfoma/index.html">
 <span class="dropdown-text">Lenfoma</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../../../statik/hastalar/diger/index.html">
 <span class="dropdown-text">DiÄŸer Mide TÃ¼mÃ¶rleri</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../../../statik/diger/ozofagus/index.html">
 <span class="dropdown-text">Ã–zofagus Kanseri</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../../../statik/diger/gerd/index.html">
 <span class="dropdown-text">GastroÃ¶zofageal ReflÃ¼</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../../../statik/diger/herni/index.html">
 <span class="dropdown-text">Hiatal Herni</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../../../statik/diger/pankreas/index.html">
 <span class="dropdown-text">Pankreas Kanseri</span></a>
  </li>  
    </ul>
  </li>
  <li class="nav-item dropdown ">
    <a class="nav-link dropdown-toggle" href="#" id="nav-menu-doktorlar-iÌ‡Ã§in" role="link" data-bs-toggle="dropdown" aria-expanded="false">
 <span class="menu-text">Doktorlar Ä°Ã§in</span>
    </a>
    <ul class="dropdown-menu dropdown-menu-end" aria-labelledby="nav-menu-doktorlar-iÌ‡Ã§in">    
        <li>
    <a class="dropdown-item" href="../../../statik/doktorlar/kilavuzlar/index.html">
 <span class="dropdown-text">GÃ¼ncel KÄ±lavuzlar</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../../../statik/doktorlar/makaleler/index.html">
 <span class="dropdown-text">Ã–nemli Makaleler</span></a>
  </li>  
    </ul>
  </li>
  <li class="nav-item">
    <a class="nav-link" href="../../../blog.html"> 
<span class="menu-text">Blog</span></a>
  </li>  
</ul>
          </div> <!-- /navcollapse -->
            <div class="quarto-navbar-tools">
</div>
      </div> <!-- /container-fluid -->
    </nav>
</header>
<!-- content -->
<header id="title-block-header" class="quarto-title-block default page-columns page-full">
  <div class="quarto-title-banner page-columns page-full">
    <div class="quarto-title column-body">
      <h1 class="title">Mide kanseri (Adenokanser)</h1>
                      </div>
  </div>
    
  
  <div class="quarto-title-meta">

      
    
      
    </div>
    
  
  </header><div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
<!-- margin-sidebar -->
    
<!-- main -->
<main class="content quarto-banner-title-block" id="quarto-document-content">





<p>Halk arasÄ±nda mide kanseri olarak bilinen tip genellikle Mide tÃ¼mÃ¶rleri iÃ§inde â€œAdenokanserâ€ alt tipidir.</p>
<section id="epidemiyoloji" class="level2">
<h2 class="anchored" data-anchor-id="epidemiyoloji">Epidemiyoloji</h2>
<p>(Stomach Cancer - 2022 GLOBOCAN Verileri) ### DÃ¼nya <em>Ä°nsidans:</em> DÃ¼nya genelinde 2022 yÄ±lÄ±nda mide kanseri, 968.784 yeni vaka ile 5. sÄ±rada yer almaktadÄ±r. Bu, mide kanserinin dÃ¼nya Ã§apÄ±nda yaygÄ±n bir problem olduÄŸunu gÃ¶stermektedir.<br>
<em>Mortalite:</em> Mide kanseri, 660.175 Ã¶lÃ¼m ile yine 5. sÄ±rada yer almaktadÄ±r.</p>
<p><img src="../../../assets/images/globocan_world.jpg" class="img-fluid" style="width:100.0%"> <em>Kaynak: GLOBOCAN 2022</em></p>
<section id="tÃ¼rkiye" class="level3">
<h3 class="anchored" data-anchor-id="tÃ¼rkiye">TÃ¼rkiye</h3>
</section>
<div class="grid">
<section id="erkekler-tÃ¼rkiye" class="level3 g-col-6">
<h3 class="anchored" data-anchor-id="erkekler-tÃ¼rkiye">ğŸ‘¨ Erkekler (TÃ¼rkiye)</h3>
<p><img src="../../../assets/images/globocan_male_tr.png" class="img-fluid" style="width:100.0%"> <em>Kaynak: GLOBOCAN 2022</em></p>
<p>Mide kanseri insidansÄ± (yeni vaka oranÄ±) 100.000 kiÅŸide 16.6, Ã¶lÃ¼m oranÄ± (mortalite) 100.000 kiÅŸide 14.2 olarak belirlenmiÅŸtir. Mide kanseri, erkeklerde en sÄ±k gÃ¶rÃ¼len kanserler arasÄ±nda 5. sÄ±rada yer almaktadÄ±r.<br>
Mortalite aÃ§Ä±sÄ±ndan ise akciÄŸer kanserinden (66.3) sonra <strong>en Ã¶lÃ¼mcÃ¼l ikinci kanser tÃ¼rÃ¼</strong>dÃ¼r.</p>
</section>
<section id="kadÄ±nlar-tÃ¼rkiye" class="level3 g-col-6">
<h3 class="anchored" data-anchor-id="kadÄ±nlar-tÃ¼rkiye">ğŸ‘© KadÄ±nlar (TÃ¼rkiye)</h3>
<p><img src="../../../assets/images/globocan_female_tr.png" class="img-fluid" style="width:100.0%"> <em>Kaynak: GLOBOCAN 2022</em></p>
<p>Mide kanseri insidansÄ± 100.000 kiÅŸide 7.7 olarak Ã¶lÃ§Ã¼lmÃ¼ÅŸtÃ¼r.<br>
Mide kanserinden Ã¶lÃ¼m oranÄ± (mortalite) 100.000 kiÅŸide 5.3 olarak kaydedilmiÅŸtir.</p>
</section>
</div>
<div class="callout callout-style-default callout-important callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Ã–nemli
</div>
</div>
<div class="callout-body-container callout-body">
<p>Dikkat Ã§ekici bir nokta, erkeklerde mide kanseri iÃ§in insidans ve mortalite oranlarÄ± arasÄ±ndaki farkÄ±n oldukÃ§a az olmasÄ±dÄ±r (16.6 vs 14.2). Bu durum, hastalÄ±ÄŸÄ±n erkeklerde tanÄ± konduÄŸunda genellikle ileri evrede olduÄŸunu ve saÄŸkalÄ±m oranlarÄ±nÄ±n dÃ¼ÅŸÃ¼k olduÄŸunu gÃ¶stermektedir.</p>
</div>
</div>
<section id="tÃ¼mÃ¼-tÃ¼rkiye" class="level3">
<h3 class="anchored" data-anchor-id="tÃ¼mÃ¼-tÃ¼rkiye">TÃ¼mÃ¼ (TÃ¼rkiye)</h3>
<p><img src="../../../assets/images/globocan_both_tr.png" class="img-fluid" style="width:100.0%"></p>
<p><em>Kaynak: GLOBOCAN 2022</em></p>
</section>
</section>
<section id="risk-faktÃ¶rleri" class="level2">
<h2 class="anchored" data-anchor-id="risk-faktÃ¶rleri">Risk FaktÃ¶rleri</h2>
<section id="enfeksiyÃ¶z-nedenler" class="level4">
<h4 class="anchored" data-anchor-id="enfeksiyÃ¶z-nedenler">1. EnfeksiyÃ¶z Nedenler</h4>
<ul>
<li>Helicobacter pylori Enfeksiyonu</li>
<li>Epstein-Barr VirÃ¼sÃ¼</li>
</ul>
</section>
<section id="yaÅŸam-tarzÄ±-ve-diyet" class="level4">
<h4 class="anchored" data-anchor-id="yaÅŸam-tarzÄ±-ve-diyet">2. YaÅŸam TarzÄ± ve Diyet</h4>
<ul>
<li>Sigara KullanÄ±mÄ±</li>
<li>AÅŸÄ±rÄ± Tuzlu ve Ä°ÅŸlenmiÅŸ GÄ±da TÃ¼ketimi</li>
<li>DÃ¼ÅŸÃ¼k Taze Meyve ve Sebze TÃ¼ketimi</li>
<li>Alkol KullanÄ±mÄ±</li>
<li>Obezite</li>
</ul>
</section>
<section id="kiÅŸisel-ve-genetik-faktÃ¶rler" class="level4">
<h4 class="anchored" data-anchor-id="kiÅŸisel-ve-genetik-faktÃ¶rler">3. KiÅŸisel ve Genetik FaktÃ¶rler</h4>
<ul>
<li>Aile Ã–ykÃ¼sÃ¼</li>
<li>Ä°leri YaÅŸ</li>
<li>Kan Grubu A</li>
<li>CDH1 Gen Mutasyonu</li>
<li>Lynch Sendromu</li>
<li>FAP (Ailevi AdenomatÃ¶z Polipozis)</li>
</ul>
</section>
<section id="tÄ±bbi-durumlar" class="level4">
<h4 class="anchored" data-anchor-id="tÄ±bbi-durumlar">4. TÄ±bbi Durumlar</h4>
<ul>
<li>Kronik Atrofik Gastrit</li>
<li>PernisiyÃ¶z Anemi</li>
<li>Ä°ntestinal Metaplazi</li>
<li>GeÃ§irilmiÅŸ Mide Cerrahisi Ã–ykÃ¼sÃ¼</li>
<li>Mide Polipleri (Ã¶zellikle adenomatÃ¶z)</li>
</ul>
</section>
</section>
<section id="tanÄ±" class="level2">
<h2 class="anchored" data-anchor-id="tanÄ±">TanÄ±</h2>
<p>Mide kanserinin tanÄ±sÄ±, Ã§eÅŸitli yÃ¶ntemlerin bir arada ve doÄŸru ÅŸekilde kullanÄ±lmasÄ±yla konur:</p>
<section id="Ã¼st-gis-endoskopi-ve-biyopsi" class="level4">
<h4 class="anchored" data-anchor-id="Ã¼st-gis-endoskopi-ve-biyopsi">1. Ãœst GIS Endoskopi ve Biyopsi</h4>
<ul>
<li><strong>AltÄ±n standarttÄ±r.</strong> LezyonlarÄ±n doÄŸrudan gÃ¶rÃ¼lmesini ve kesin tanÄ± iÃ§in Ã§oklu biyopsi alÄ±nmasÄ±nÄ± saÄŸlar.</li>
<li><strong>Kromoskopi ile biyopsi:</strong> ÅÃ¼pheli alanlarda kromoskopi kullanÄ±larak tanÄ± doÄŸruluÄŸu artÄ±rÄ±lÄ±r.</li>
</ul>
</section>
<section id="gÃ¶rÃ¼ntÃ¼leme-yÃ¶ntemleri" class="level4">
<h4 class="anchored" data-anchor-id="gÃ¶rÃ¼ntÃ¼leme-yÃ¶ntemleri">2. GÃ¶rÃ¼ntÃ¼leme YÃ¶ntemleri</h4>
<ul>
<li><strong>BilgisayarlÄ± Tomografi (BT):</strong> Evreleme ve metastaz deÄŸerlendirmesinde temel yÃ¶ntemdir.</li>
<li><strong>Manyetik Rezonans (MR):</strong> Ã–zellikle lokal ve bÃ¶lgesel yayÄ±lÄ±mÄ±n deÄŸerlendirilmesinde faydalÄ±dÄ±r.</li>
<li><strong>PET/BT:</strong> Uzak metastaz araÅŸtÄ±rmasÄ±nda yararlÄ±dÄ±r; ancak rutin kullanÄ±mÄ± her hasta iÃ§in gerekli deÄŸildir, Ã¶zellikle ileri hastalÄ±k veya ÅŸÃ¼pheli yayÄ±lÄ±m durumlarÄ±nda tercih edilir. Mide kanserindeki duyarlÄ±lÄ±ÄŸÄ±, diÄŸer kanser tÃ¼rlerine oranla daha dÃ¼ÅŸÃ¼ktÃ¼r.</li>
</ul>
</section>
<section id="laboratuvar-testleri" class="level4">
<h4 class="anchored" data-anchor-id="laboratuvar-testleri">3. Laboratuvar Testleri</h4>
<ul>
<li><strong>Tam kan sayÄ±mÄ±:</strong> Hastalarda sÄ±klÄ±kla anemi bulunabilir.</li>
<li><strong>Biyokimya:</strong> KaraciÄŸer ve bÃ¶brek fonksiyonlarÄ± deÄŸerlendirilir; sistemik duruma iliÅŸkin bilgi verir.</li>
<li><strong>TÃ¼mÃ¶r belirteÃ§leri (CEA, CA 19-9, CA 72-4):</strong> Takip ve ileri evre hastalÄ±kta destekleyici rol oynar, tek baÅŸÄ±na tanÄ± deÄŸeri sÄ±nÄ±rlÄ±dÄ±r.</li>
</ul>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Not
</div>
</div>
<div class="callout-body-container callout-body">
<p>Mide kanseri tanÄ±sÄ±nda <strong>endoskopi ve biyopsi</strong> esas olup, gÃ¶rÃ¼ntÃ¼leme yÃ¶ntemleri ve laboratuvar testleri hastalÄ±ÄŸÄ±n kapsamlÄ± deÄŸerlendirilmesi ve tedavi planÄ± oluÅŸturulmasÄ±nda tamamlayÄ±cÄ±dÄ±r. TanÄ±da multidisipliner yaklaÅŸÄ±m bÃ¼yÃ¼k Ã¶nem taÅŸÄ±r.</p>
</div>
</div>
</section>
</section>
<section id="evreleme" class="level2">
<h2 class="anchored" data-anchor-id="evreleme">Evreleme</h2>
<p><strong>Evreleme</strong>, kanserli bir hastada tÃ¼mÃ¶rÃ¼n vÃ¼cut iÃ§indeki yayÄ±lÄ±m derecesinin, yani hastalÄ±ÄŸÄ±n ne kadar ilerlediÄŸinin belirlenmesi iÅŸlemidir. Mide kanserinde evreleme, tÃ¼mÃ¶rÃ¼n mide duvarÄ±nda ne kadar derinlikte olduÄŸu (primer tÃ¼mÃ¶r), Ã§evre lenf dÃ¼ÄŸÃ¼mlerine ya da uzak organlara (metastaz) yayÄ±lÄ±p yayÄ±lmadÄ±ÄŸÄ± gibi temel sorulara yanÄ±t bulmayÄ± amaÃ§lar.</p>
<section id="neden-evreleme-yapÄ±lÄ±r" class="level3">
<h3 class="anchored" data-anchor-id="neden-evreleme-yapÄ±lÄ±r">Neden Evreleme YapÄ±lÄ±r?</h3>
<ul>
<li><strong>Tedavi PlanÄ±:</strong> HastalÄ±ÄŸÄ±n evresi, uygulanacak tedavinin (cerrahi, kemoterapi, radyoterapi veya hedefe yÃ¶nelik tedaviler) seÃ§iminde belirleyicidir.<br>
</li>
<li><strong>Prognozun Belirlenmesi:</strong> Evre, hastalÄ±ÄŸÄ±n gidiÅŸatÄ± ve saÄŸkalÄ±m oranlarÄ± hakkÄ±nda en Ã¶nemli bilgi kaynaÄŸÄ±dÄ±r.</li>
<li><strong>Tedavi EtkinliÄŸinin DeÄŸerlendirilmesi:</strong> Tedavi sonrasÄ± sÃ¼reÃ§te hastalÄ±ÄŸÄ±n tekrarlama (nÃ¼ks) veya ilerleme riskini ortaya koymak iÃ§in gereklidir.</li>
<li><strong>Klinik AraÅŸtÄ±rmalara Uygunluk:</strong> HastalarÄ±n araÅŸtÄ±rma ve klinik Ã§alÄ±ÅŸmalara uygunluÄŸunu deÄŸerlendirmek iÃ§in de kullanÄ±lÄ±r.</li>
</ul>
</section>
<section id="nasÄ±l-yapÄ±lÄ±r" class="level3">
<h3 class="anchored" data-anchor-id="nasÄ±l-yapÄ±lÄ±r">NasÄ±l YapÄ±lÄ±r?</h3>
<p>Mide kanserinde evreleme, Ã§ok yÃ¶nlÃ¼ bir yaklaÅŸÄ±mla yapÄ±lÄ±r. Bu sÃ¼reÃ§te aÅŸaÄŸÄ±daki unsurlar deÄŸerlendirilir:</p>
<section id="tnm-sistemi" class="level4">
<h4 class="anchored" data-anchor-id="tnm-sistemi">TNM Sistemi</h4>
<p>DÃ¼nya genelinde en Ã§ok kullanÄ±lan sistem <strong>â€œTNM SÄ±nÄ±flamasÄ±â€</strong>dÄ±r (UICC/AJCC).<br>
- <strong>T (TÃ¼mÃ¶r):</strong> TÃ¼mÃ¶rÃ¼n mide duvarÄ±nda ne kadar derine uzandÄ±ÄŸÄ± (T1-T4).<br>
- <strong>N (Nod):</strong> YakÄ±n (bÃ¶lgesel) lenf dÃ¼ÄŸÃ¼mlerinde tutulum (N0-N3).<br>
- <strong>M (Metastaz):</strong> Uzak organlara yayÄ±lÄ±m (M0: yok, M1: var).</p>
<p>Bu kriterlerle;<br>
- Evre 0â€™dan (en erken)<br>
- Evre IVâ€™e (uzak metastaz varlÄ±ÄŸÄ±) kadar sÄ±ralanÄ±r.</p>
</section>
<section id="evreleme-yÃ¶ntemleri" class="level4">
<h4 class="anchored" data-anchor-id="evreleme-yÃ¶ntemleri">Evreleme YÃ¶ntemleri</h4>
<ol type="1">
<li><strong>GÃ¶rÃ¼ntÃ¼leme YÃ¶ntemleri</strong>
<ul>
<li><strong>BT (BilgisayarlÄ± Tomografi):</strong> KarÄ±n ve gÃ¶ÄŸÃ¼s BT, yayÄ±lÄ±mÄ±n ve lenf nodlarÄ±nÄ±n deÄŸerlendirilmesinde ana yÃ¶ntemdir.<br>
</li>
<li><strong>MR (Manyetik Rezonans):</strong> Ã–zellikle pelvik yayÄ±lÄ±m ya da karaciÄŸer lezyonlarÄ±nda ek bilgi saÄŸlar.</li>
<li><strong>PET/BT:</strong> Uzak metastaz ÅŸÃ¼phesi varsa kullanÄ±lÄ±r. Ancak, dÃ¼ÅŸÃ¼k dereceli veya diffÃ¼z tip tÃ¼mÃ¶rlerde duyarlÄ±lÄ±ÄŸÄ± sÄ±nÄ±rlÄ± olabilir.</li>
<li><strong>Endoskopik Ultrason (EUS):</strong> TÃ¼mÃ¶rÃ¼n mide duvarÄ±ndaki derinliÄŸi ve Ã§evre lenf nodu tutulumunun deÄŸerlendirilmesinde Ã§ok deÄŸerlidir.</li>
<li><strong>Ekografi (USG):</strong> KaraciÄŸer metastazÄ± yÃ¶nÃ¼nden tarama amacÄ±yla yapÄ±labilir.</li>
</ul></li>
<li><strong>TanÄ± AmaÃ§lÄ± Cerrahi</strong>
<ul>
<li><strong>TanÄ±sal Laparoskopi:</strong> Ã–zellikle evre III hastalarda, BT/MR ile saptanamayan kÃ¼Ã§Ã¼k karÄ±n iÃ§i metastazlarÄ±n (Ã¶zellikle periton) tespiti iÃ§in uygulanÄ±r. Cerrahi planlamadan Ã¶nce Ã¶nemli bilgi saÄŸlar.</li>
</ul></li>
<li><strong>Ek Testler</strong>
<ul>
<li><strong>Laboratuvar Tetkikleri:</strong> KaraciÄŸer fonksiyon testleri, tÃ¼mÃ¶r belirteÃ§leri (Ã¶rn. CEA, CA 19-9) destekleyici olur ancak tek baÅŸÄ±na tanÄ± koydurmaz.</li>
</ul></li>
</ol>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Not
</div>
</div>
<div class="callout-body-container callout-body">
<p>Evreleme, mide kanseri yÃ¶netiminde merkezÃ® bir Ã¶neme sahiptir. HastalÄ±ÄŸÄ±n evresi; hastanÄ±n tedavi ÅŸemasÄ±nÄ±, iyileÅŸme ÅŸansÄ±nÄ± ve takip stratejilerini belirler. Bu nedenle, evreleme multidisipliner ekip Ã§alÄ±ÅŸmasÄ±yla, hem klinik (gÃ¶rÃ¼ntÃ¼leme, laboratuvar) hem de gerektiÄŸinde cerrahi yÃ¶ntemlerle titizlikle yapÄ±lmalÄ±dÄ±r.</p>
</div>
</div>
</section>
</section>
</section>
<section id="tedavi" class="level2">
<h2 class="anchored" data-anchor-id="tedavi">Tedavi</h2>
<p>Mide kanseri tedavisi, hastalÄ±ÄŸÄ±n evresi, tÃ¼mÃ¶rÃ¼n yerleÅŸimi, hastanÄ±n performans durumu ve ek hastalÄ±klar gÃ¶z Ã¶nÃ¼ne alÄ±narak planlanÄ±r. SeÃ§ilecek tedavi genellikle cerrahi, kemoterapi, radyoterapi ve hedefe yÃ¶nelik/immÃ¼noterapi seÃ§eneklerinin bir kombinasyonundan oluÅŸur.</p>
<section id="cerrahi-tedavi" class="level4">
<h4 class="anchored" data-anchor-id="cerrahi-tedavi">1. Cerrahi Tedavi</h4>
<ul>
<li><strong>KÃ¼Ã§Ã¼k ve erken evre tÃ¼mÃ¶rlerde</strong> (Evre 0-I): Cerrahi (total ya da subtotal gastrektomi) en etkili tedavidir. Japonya ve Kore gibi DoÄŸu Asya Ã¼lkelerinde â€œendoskopik mukozal rezeksiyon (EMR)â€, <em>erken mide kanseri</em> (derinlik ve lenf nodu riski az olanlar) iÃ§in sÄ±kÃ§a tercih edilir.</li>
<li><strong>Lenf nodu diseksiyonu</strong>: D2 disseksiyon (geniÅŸletilmiÅŸ lenf nodu Ã§Ä±kartÄ±lmasÄ±) Japonya/Koreâ€™de rutin (standart), BatÄ± kÄ±lavuzlarÄ±nda (NCCN, ESMO) ise, deneyimli merkezlerde yapÄ±lmasÄ± Ã¶nerilir.</li>
</ul>
</section>
<section id="perioperatif-adjuvan-neoadjuvan-kemoterapi" class="level4">
<h4 class="anchored" data-anchor-id="perioperatif-adjuvan-neoadjuvan-kemoterapi">2. Perioperatif / Adjuvan / Neoadjuvan Kemoterapi</h4>
<ul>
<li><strong>NCCN (ABD)</strong> ve <strong>ESMO (Avrupa)</strong>, tÃ¼mÃ¶r mide duvarÄ±nÄ±n derinliÄŸine inmiÅŸse (T2 veya Ã¼stÃ¼ ve/veya lenf nodu pozitifliÄŸi varsa) perioperatif (ameliyat Ã¶ncesi ve sonrasÄ±) kemoterapiyi standart olarak Ã¶neriyor.</li>
<li><strong>Japon ve Kore kÄ±lavuzlarÄ±</strong> ise, Ã¶zellikle D2 diseksiyon sonrasÄ± genellikle adjuvan (ameliyat sonrasÄ±) S-1 (bir oral fluoropirimidin) gibi ajanlarla kemoterapiyi tercih edebiliyor.</li>
<li><strong>BatÄ±</strong>da perioperatif FLOT (5-FU, LÃ¶kavorin, Oxaliplatin, Docetaxel kombinasyonu) protokolÃ¼ sÄ±klÄ±kla Ã¶nerilir.</li>
<li><strong>DoÄŸu Asya</strong>da S-1 veya CapeOX gibi ajanlar Ã¶n plandadÄ±r.</li>
</ul>
</section>
<section id="radyoterapi" class="level4">
<h4 class="anchored" data-anchor-id="radyoterapi">3. Radyoterapi</h4>
<ul>
<li><strong>Postoperatif kemoradyoterapi</strong> BatÄ±â€™da (Ã¶zellikle D0/D1 lenfadenektomi yapÄ±lan hastalarda veya yetersiz cerrahi sÄ±nÄ±r varsa) daha Ã§ok kullanÄ±lÄ±r.</li>
<li>DoÄŸu Asya kÄ±lavuzlarÄ±nda (Japonya, Kore) D2 disseksiyonun standart olmasÄ± nedeniyle rutin radyoterapi daha az Ã¶nerilir.</li>
</ul>
</section>
<section id="hedefe-yÃ¶nelik-tedaviler-ve-immÃ¼noterapi" class="level4">
<h4 class="anchored" data-anchor-id="hedefe-yÃ¶nelik-tedaviler-ve-immÃ¼noterapi">4. Hedefe YÃ¶nelik Tedaviler ve Ä°mmÃ¼noterapi</h4>
<ul>
<li><strong>HER2 pozitif tÃ¼mÃ¶rlerde:</strong> Trastuzumab (anti-HER2 antikor) kombinasyon kemoterapi ile birlikte kullanÄ±labilir (tÃ¼m kÄ±lavuzlarda ortak Ã¶neri).</li>
<li><strong>PD-1/PD-L1 inhibitÃ¶rleri</strong> (Ã¶rn. pembrolizumab, nivolumab): Ã–zellikle ilerlemiÅŸ evre/refrakter tÃ¼mÃ¶rlerde veya yÃ¼ksek MSI/dMMR (mikrosatellit instabilite/yetersiz DNA tamir) durumu varsa Ã§oÄŸu kÄ±lavuz bu ajanlarÄ± Ã¶neriyor.</li>
<li><strong>Claudin 18.2 hedefli ajanlar</strong> (Ã¶rn. zolbetuximab) ve diÄŸer molekÃ¼ler hedefli tedaviler, son yÄ±llarda klinik Ã§alÄ±ÅŸmalarda umut vaat ediyor.</li>
</ul>
</section>
<section id="gÃ¼ncel-kÄ±lavuzlar-arasÄ±ndaki-temel-farklÄ±lÄ±klar" class="level4">
<h4 class="anchored" data-anchor-id="gÃ¼ncel-kÄ±lavuzlar-arasÄ±ndaki-temel-farklÄ±lÄ±klar">GÃ¼ncel KÄ±lavuzlar ArasÄ±ndaki Temel FarklÄ±lÄ±klar</h4>
<table class="caption-top table">
<colgroup>
<col style="width: 32%">
<col style="width: 19%">
<col style="width: 19%">
<col style="width: 28%">
</colgroup>
<thead>
<tr class="header">
<th></th>
<th>NCCN (ABD)</th>
<th>ESMO (Avrupa)</th>
<th>Japon/Kore KÄ±lavuzlarÄ±</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Endoskopik rezeksiyon</strong></td>
<td>SeÃ§ilmiÅŸ hastada</td>
<td>SeÃ§ilmiÅŸ hastada</td>
<td>Daha yaygÄ±n, erken evrede</td>
</tr>
<tr class="even">
<td><strong>Kemoterapi yaklaÅŸÄ±mlarÄ±</strong></td>
<td>Daha agresif, perioperatif FLOT</td>
<td>Perioperatif FLOT Ã¶nerisi baskÄ±n</td>
<td>Genellikle adjuvan kemoterapi, S-1 Ã¶n planda</td>
</tr>
<tr class="odd">
<td><strong>Lenf nodu diseksiyonu</strong></td>
<td>D1/D2, merkez deneyimine baÄŸlÄ±</td>
<td>D2 Ã¶nerilebilir</td>
<td>D2 diseksiyon standart</td>
</tr>
<tr class="even">
<td><strong>Radyoterapi</strong></td>
<td>Yetersiz cerrahi yapÄ±lan olguda adjuvan</td>
<td>SeÃ§ilmiÅŸ olguda</td>
<td>Nadiren, genelde gerek yok</td>
</tr>
<tr class="odd">
<td><strong>Hedefe yÃ¶nelik/immÃ¼noterapi</strong></td>
<td>HER2+, MSI/dMMR+, 3. basamakta PD-1 ajanlarÄ±</td>
<td>HER2+, PD-1 ajanlarÄ±</td>
<td>Benzer, gÃ¼ncel eklemeler mevcut</td>
</tr>
</tbody>
</table>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Not
</div>
</div>
<div class="callout-body-container callout-body">
<ul>
<li><strong>Tedavi kararlarÄ±</strong> mutlaka multidisipliner bir ekip tarafÄ±ndan verilmelidir.</li>
<li><strong>TÃ¼mÃ¶rÃ¼n biyolojisi (HER2, MSI, PD-L1)</strong> ve hastanÄ±n genel durumu standart yaklaÅŸÄ±mlarÄ± deÄŸiÅŸtirebilir.</li>
<li><strong>BatÄ± Ã¼lkelerindeki yaklaÅŸÄ±m</strong>, sÄ±klÄ±kla daha agresif kemoterapi ve radyoterapiyi iÃ§erirken, <strong>DoÄŸu Asya</strong> cerrahide daha radikal yÃ¶ntemleri ve farklÄ± ajanlarÄ± Ã¶n plana Ã§Ä±karÄ±r.</li>
<li><strong>Yeni molekÃ¼ler hedefler</strong> ve immÃ¼noterapiler, klinik araÅŸtÄ±rmalarda ilgi odaÄŸÄ±dÄ±r ve standarda girmeye baÅŸlamÄ±ÅŸtÄ±r.</li>
</ul>
</div>
</div>
</section>
</section>
<section id="prognoz" class="level2">
<h2 class="anchored" data-anchor-id="prognoz">Prognoz</h2>
<p>Mide kanserinin prognozu, yani hastalÄ±ÄŸÄ±n gidiÅŸatÄ± ve beklenen saÄŸkalÄ±m sÃ¼resi, baÅŸta tanÄ± anÄ±ndaki evre olmak Ã¼zere birÃ§ok faktÃ¶re baÄŸlÄ±dÄ±r. Son yÄ±llarda tanÄ± ve tedavideki geliÅŸmelere raÄŸmen, mide kanseri dÃ¼nyada halen Ã¶nemli bir Ã¶lÃ¼m nedenidir.</p>
<section id="evrelere-gÃ¶re-saÄŸkalÄ±m-oranlarÄ±" class="level3">
<h3 class="anchored" data-anchor-id="evrelere-gÃ¶re-saÄŸkalÄ±m-oranlarÄ±">1. Evrelere GÃ¶re SaÄŸkalÄ±m OranlarÄ±</h3>
<p>Mide kanseri iÃ§in beÅŸ yÄ±llÄ±k saÄŸkalÄ±m oranlarÄ± genellikle ÅŸu ÅŸekildedir:</p>
<table class="caption-top table">
<thead>
<tr class="header">
<th>Evre</th>
<th>ABD/Avrupa (%)</th>
<th>Japonya/Kore (%)</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Evre I</td>
<td>70-90</td>
<td>90-95</td>
</tr>
<tr class="even">
<td>Evre II</td>
<td>45-60</td>
<td>60-80</td>
</tr>
<tr class="odd">
<td>Evre III</td>
<td>20-35</td>
<td>30-50</td>
</tr>
<tr class="even">
<td>Evre IV</td>
<td>5-10</td>
<td>10-20</td>
</tr>
</tbody>
</table>
<ul>
<li><strong>Erken evrede tanÄ±</strong> koyulan hastalarda saÄŸkalÄ±m Ã§ok yÃ¼ksektir.<br>
</li>
<li><strong>GeliÅŸmiÅŸ Ã¼lkeler</strong>de tarama programlarÄ±nÄ±n yaygÄ±nlÄ±ÄŸÄ±na baÄŸlÄ± olarak DoÄŸu Asyaâ€™da (Ã¶zellikle Japonya ve Kore) hastalÄ±k genellikle daha erken evrede yakalanÄ±r ve saÄŸkalÄ±m oranlarÄ± BatÄ± Ã¼lkelerine gÃ¶re belirgin ÅŸekilde daha iyidir.</li>
<li><strong>TÃ¼rkiye</strong> gibi Ã¼lkelerde erken tanÄ± oranÄ± DoÄŸu Asyaâ€™ya gÃ¶re dÃ¼ÅŸÃ¼k, BatÄ± Ã¼lkelerine gÃ¶reyse biraz daha iyileÅŸme eÄŸilimindedir.</li>
</ul>
</section>
<section id="prognozu-belirleyen-faktÃ¶rler" class="level3">
<h3 class="anchored" data-anchor-id="prognozu-belirleyen-faktÃ¶rler">2. Prognozu Belirleyen FaktÃ¶rler</h3>
<p>Prognoz Ã¼zerinde etkili olan baÅŸlÄ±ca faktÃ¶rler ÅŸunlardÄ±r:</p>
<section id="evre-en-kritik-faktÃ¶r" class="level4">
<h4 class="anchored" data-anchor-id="evre-en-kritik-faktÃ¶r">1. Evre (EN KRÄ°TÄ°K FAKTÃ–R)</h4>
<ul>
<li>Primer tÃ¼mÃ¶rÃ¼n mide duvarÄ±na invazyon derinliÄŸi (T aÅŸamasÄ±)</li>
<li>BÃ¶lgesel lenf nodu tutulumu (N aÅŸamasÄ±)</li>
<li>Uzak metastaz varlÄ±ÄŸÄ± (M aÅŸamasÄ±)</li>
</ul>
</section>
<section id="tÃ¼mÃ¶rÃ¼n-lokasyonu" class="level4">
<h4 class="anchored" data-anchor-id="tÃ¼mÃ¶rÃ¼n-lokasyonu">2. TÃ¼mÃ¶rÃ¼n Lokasyonu</h4>
<ul>
<li>Proksimal (kardia/fundus) yerleÅŸimli tÃ¼mÃ¶rlerin prognozu genellikle daha kÃ¶tÃ¼dÃ¼r.</li>
<li>Antrum ve distal yerleÅŸimli tÃ¼mÃ¶rlerde saÄŸkalÄ±m daha yÃ¼ksektir.</li>
</ul>
</section>
<section id="tÃ¼mÃ¶rÃ¼n-histolojik-tipi" class="level4">
<h4 class="anchored" data-anchor-id="tÃ¼mÃ¶rÃ¼n-histolojik-tipi">3. TÃ¼mÃ¶rÃ¼n Histolojik Tipi</h4>
<ul>
<li><strong>Ä°ntestinal tip</strong> (Lauren sÄ±nÄ±flamasÄ±): Prognozu genellikle daha iyidir.</li>
<li><strong>DiffÃ¼z tip</strong> (Ã¶zellikle signet-ring hÃ¼creli): Daha agresiftir ve saÄŸkalÄ±m dÃ¼ÅŸÃ¼k olabilir.</li>
</ul>
</section>
<section id="rezeksiyon-durumu" class="level4">
<h4 class="anchored" data-anchor-id="rezeksiyon-durumu">4. Rezeksiyon Durumu</h4>
<ul>
<li><strong>R0 rezeksiyon</strong> (tÃ¼mÃ¶rÃ¼n mikroskopik olarak tam Ã§Ä±karÄ±lmasÄ±) yapÄ±lan hastalarda prognoz anlamlÄ± ÅŸekilde daha iyidir.</li>
<li><strong>Pozitif cerrahi sÄ±nÄ±r (R1/R2 rezeksiyon)</strong>, nÃ¼ks riskini artÄ±rÄ±r ve saÄŸkalÄ±mÄ± olumsuz etkiler.</li>
</ul>
</section>
<section id="lenf-nodu-tutulumu-ve-dizilimi" class="level4">
<h4 class="anchored" data-anchor-id="lenf-nodu-tutulumu-ve-dizilimi">5. Lenf Nodu Tutulumu ve Dizilimi</h4>
<ul>
<li>Tutulan lenf nodu sayÄ±sÄ± ve oranÄ±, saÄŸkalÄ±m iÃ§in Ã§ok Ã¶nemlidir.</li>
</ul>
</section>
<section id="molekÃ¼ler-ve-biyolojik-faktÃ¶rler" class="level4">
<h4 class="anchored" data-anchor-id="molekÃ¼ler-ve-biyolojik-faktÃ¶rler">6. MolekÃ¼ler ve Biyolojik FaktÃ¶rler</h4>
<ul>
<li><strong>HER2 pozitifliÄŸi:</strong> Tedaviye uygunluk saÄŸlar ve bazÄ± hastalarda saÄŸkalÄ±mÄ± uzatabilir.</li>
<li><strong>MSI/dMMR yÃ¼ksekliÄŸi:</strong> Bu hastalar baÄŸÄ±ÅŸÄ±klÄ±k kontrol noktasÄ± inhibitÃ¶rlerinden daha fazla fayda gÃ¶rebilir.</li>
<li>DiÄŸer genetik ve molekÃ¼ler deÄŸiÅŸiklikler de araÅŸtÄ±rÄ±lmaktadÄ±r.</li>
</ul>
</section>
<section id="hastanÄ±n-genel-durumu-ve-eÅŸlik-eden-hastalÄ±klar" class="level4">
<h4 class="anchored" data-anchor-id="hastanÄ±n-genel-durumu-ve-eÅŸlik-eden-hastalÄ±klar">7. HastanÄ±n Genel Durumu ve EÅŸlik Eden HastalÄ±klar</h4>
<ul>
<li>KÃ¶tÃ¼ performans durumu, ciddi ek hastalÄ±klar (Ã¶r. diyabet, kalp yetmezliÄŸi) prognozu olumsuz etkiler.</li>
</ul>
</section>
<section id="uygulanan-tedavi" class="level4">
<h4 class="anchored" data-anchor-id="uygulanan-tedavi">8. Uygulanan Tedavi</h4>
<ul>
<li>Cerrahi kalitesi (D1-D2 diseksiyon, R0 rezeksiyon)</li>
<li>DoÄŸru ve zamanÄ±nda adjuvan/perioperatif tedavi uygulamasÄ±</li>
</ul>
</section>
<section id="Ã¼lke-ve-saÄŸlÄ±k-altyapÄ±sÄ±" class="level4">
<h4 class="anchored" data-anchor-id="Ã¼lke-ve-saÄŸlÄ±k-altyapÄ±sÄ±">9. Ãœlke ve SaÄŸlÄ±k AltyapÄ±sÄ±</h4>
<ul>
<li>Erken tanÄ± olanaklarÄ±, tarama programlarÄ±</li>
<li>Deneyimli merkezlere eriÅŸim, multidisipliner ekip yaklaÅŸÄ±mÄ±</li>
</ul>
</section>
</section>
<section id="Ã¼lkeler-ve-bÃ¶lgeler-arasÄ±ndaki-farklar" class="level3">
<h3 class="anchored" data-anchor-id="Ã¼lkeler-ve-bÃ¶lgeler-arasÄ±ndaki-farklar">3. Ãœlkeler ve BÃ¶lgeler ArasÄ±ndaki Farklar</h3>
<ul>
<li><strong>Japonya ve Kore:</strong> YoÄŸun tarama programlarÄ± sayesinde vakalarÄ±n %50â€™den fazlasÄ± erken evrede tanÄ±nÄ±r. Bu nedenle saÄŸkalÄ±m oranlarÄ± BatÄ± Ã¼lkelerine gÃ¶re Ã§ok daha yÃ¼ksektir.</li>
<li><strong>ABD/Avrupa:</strong> Genellikle daha ileri evrede tanÄ± konulur, saÄŸkalÄ±m oranÄ± dÃ¼ÅŸÃ¼ktÃ¼r.</li>
<li><strong>GeliÅŸmekte olan Ã¼lkeler:</strong> Erken tanÄ± oranÄ± ve tedaviye eriÅŸim, prognozda belirleyici olmaktadÄ±r.</li>
</ul>
</section>
<section id="gÃ¼ncel-yaklaÅŸÄ±m-ve-takip" class="level3">
<h3 class="anchored" data-anchor-id="gÃ¼ncel-yaklaÅŸÄ±m-ve-takip">4. GÃ¼ncel YaklaÅŸÄ±m ve Takip</h3>
<ul>
<li>GÃ¼nÃ¼mÃ¼zde <strong>tÃ¼mÃ¶rÃ¼n biyobelirteÃ§leri</strong> (HER2, MSI, PD-L1) de prognozda ve tedavi planÄ± seÃ§iminde gitgide daha Ã§ok Ã¶nem kazanmaktadÄ±r.</li>
<li><strong>Takip ve erken nÃ¼ks tespiti</strong>, saÄŸkalÄ±m Ã¼zerinde pozitif etki yaratabilir.</li>
</ul>
<hr>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Not
</div>
</div>
<div class="callout-body-container callout-body">
<p>Mide kanserinin prognozu Ã§ok sayÄ±da faktÃ¶re baÄŸlÄ±dÄ±r. Erken teÅŸhis ve modern tedaviyle saÄŸkalÄ±m oranlarÄ± belirgin ÅŸekilde artmaktadÄ±r. DoÄŸu Asya Ã¼lkelerindeki baÅŸarÄ±lÄ± tarama ve tedavi stratejileri, BatÄ±â€™ya gÃ¶re saÄŸkalÄ±mÄ± Ã§ok daha yÃ¼kseltmektedir. TÃ¼m hastalarda en iyi sonuÃ§ iÃ§in multidisipliner yaklaÅŸÄ±m ve bireyselleÅŸtirilmiÅŸ tedavi esastÄ±r.</p>
</div>
</div>
<p><strong>Sayfa iÃ§eriÄŸi sadece bilgilendirme amaÃ§lÄ±dÄ±r, tanÄ± ve tedavi iÃ§in mutlaka doktorunuza baÅŸvurunuz.</strong></p>


</section>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
  window.document.addEventListener("DOMContentLoaded", function (event) {
    const icon = "î§‹";
    const anchorJS = new window.AnchorJS();
    anchorJS.options = {
      placement: 'right',
      icon: icon
    };
    anchorJS.add('.anchored');
    const isCodeAnnotation = (el) => {
      for (const clz of el.classList) {
        if (clz.startsWith('code-annotation-')) {                     
          return true;
        }
      }
      return false;
    }
    const onCopySuccess = function(e) {
      // button target
      const button = e.trigger;
      // don't keep focus
      button.blur();
      // flash "checked"
      button.classList.add('code-copy-button-checked');
      var currentTitle = button.getAttribute("title");
      button.setAttribute("title", "KopyalandÄ±");
      let tooltip;
      if (window.bootstrap) {
        button.setAttribute("data-bs-toggle", "tooltip");
        button.setAttribute("data-bs-placement", "left");
        button.setAttribute("data-bs-title", "KopyalandÄ±");
        tooltip = new bootstrap.Tooltip(button, 
          { trigger: "manual", 
            customClass: "code-copy-button-tooltip",
            offset: [0, -8]});
        tooltip.show();    
      }
      setTimeout(function() {
        if (tooltip) {
          tooltip.hide();
          button.removeAttribute("data-bs-title");
          button.removeAttribute("data-bs-toggle");
          button.removeAttribute("data-bs-placement");
        }
        button.setAttribute("title", currentTitle);
        button.classList.remove('code-copy-button-checked');
      }, 1000);
      // clear code selection
      e.clearSelection();
    }
    const getTextToCopy = function(trigger) {
        const codeEl = trigger.previousElementSibling.cloneNode(true);
        for (const childEl of codeEl.children) {
          if (isCodeAnnotation(childEl)) {
            childEl.remove();
          }
        }
        return codeEl.innerText;
    }
    const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
      text: getTextToCopy
    });
    clipboard.on('success', onCopySuccess);
    if (window.document.getElementById('quarto-embedded-source-code-modal')) {
      const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
        text: getTextToCopy,
        container: window.document.getElementById('quarto-embedded-source-code-modal')
      });
      clipboardModal.on('success', onCopySuccess);
    }
      var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
      var mailtoRegex = new RegExp(/^mailto:/);
        var filterRegex = new RegExp("https:\/\/midekanseri\.org\/");
      var isInternal = (href) => {
          return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
      }
      // Inspect non-navigation links and adorn them if external
     var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
      for (var i=0; i<links.length; i++) {
        const link = links[i];
        if (!isInternal(link.href)) {
          // undo the damage that might have been done by quarto-nav.js in the case of
          // links that we want to consider external
          if (link.dataset.originalHref !== undefined) {
            link.href = link.dataset.originalHref;
          }
        }
      }
    function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
      const config = {
        allowHTML: true,
        maxWidth: 500,
        delay: 100,
        arrow: false,
        appendTo: function(el) {
            return el.parentElement;
        },
        interactive: true,
        interactiveBorder: 10,
        theme: 'quarto',
        placement: 'bottom-start',
      };
      if (contentFn) {
        config.content = contentFn;
      }
      if (onTriggerFn) {
        config.onTrigger = onTriggerFn;
      }
      if (onUntriggerFn) {
        config.onUntrigger = onUntriggerFn;
      }
      window.tippy(el, config); 
    }
    const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
    for (var i=0; i<noterefs.length; i++) {
      const ref = noterefs[i];
      tippyHover(ref, function() {
        // use id or data attribute instead here
        let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
        try { href = new URL(href).hash; } catch {}
        const id = href.replace(/^#\/?/, "");
        const note = window.document.getElementById(id);
        if (note) {
          return note.innerHTML;
        } else {
          return "";
        }
      });
    }
    const xrefs = window.document.querySelectorAll('a.quarto-xref');
    const processXRef = (id, note) => {
      // Strip column container classes
      const stripColumnClz = (el) => {
        el.classList.remove("page-full", "page-columns");
        if (el.children) {
          for (const child of el.children) {
            stripColumnClz(child);
          }
        }
      }
      stripColumnClz(note)
      if (id === null || id.startsWith('sec-')) {
        // Special case sections, only their first couple elements
        const container = document.createElement("div");
        if (note.children && note.children.length > 2) {
          container.appendChild(note.children[0].cloneNode(true));
          for (let i = 1; i < note.children.length; i++) {
            const child = note.children[i];
            if (child.tagName === "P" && child.innerText === "") {
              continue;
            } else {
              container.appendChild(child.cloneNode(true));
              break;
            }
          }
          if (window.Quarto?.typesetMath) {
            window.Quarto.typesetMath(container);
          }
          return container.innerHTML
        } else {
          if (window.Quarto?.typesetMath) {
            window.Quarto.typesetMath(note);
          }
          return note.innerHTML;
        }
      } else {
        // Remove any anchor links if they are present
        const anchorLink = note.querySelector('a.anchorjs-link');
        if (anchorLink) {
          anchorLink.remove();
        }
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(note);
        }
        if (note.classList.contains("callout")) {
          return note.outerHTML;
        } else {
          return note.innerHTML;
        }
      }
    }
    for (var i=0; i<xrefs.length; i++) {
      const xref = xrefs[i];
      tippyHover(xref, undefined, function(instance) {
        instance.disable();
        let url = xref.getAttribute('href');
        let hash = undefined; 
        if (url.startsWith('#')) {
          hash = url;
        } else {
          try { hash = new URL(url).hash; } catch {}
        }
        if (hash) {
          const id = hash.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          if (note !== null) {
            try {
              const html = processXRef(id, note.cloneNode(true));
              instance.setContent(html);
            } finally {
              instance.enable();
              instance.show();
            }
          } else {
            // See if we can fetch this
            fetch(url.split('#')[0])
            .then(res => res.text())
            .then(html => {
              const parser = new DOMParser();
              const htmlDoc = parser.parseFromString(html, "text/html");
              const note = htmlDoc.getElementById(id);
              if (note !== null) {
                const html = processXRef(id, note);
                instance.setContent(html);
              } 
            }).finally(() => {
              instance.enable();
              instance.show();
            });
          }
        } else {
          // See if we can fetch a full url (with no hash to target)
          // This is a special case and we should probably do some content thinning / targeting
          fetch(url)
          .then(res => res.text())
          .then(html => {
            const parser = new DOMParser();
            const htmlDoc = parser.parseFromString(html, "text/html");
            const note = htmlDoc.querySelector('main.content');
            if (note !== null) {
              // This should only happen for chapter cross references
              // (since there is no id in the URL)
              // remove the first header
              if (note.children.length > 0 && note.children[0].tagName === "HEADER") {
                note.children[0].remove();
              }
              const html = processXRef(null, note);
              instance.setContent(html);
            } 
          }).finally(() => {
            instance.enable();
            instance.show();
          });
        }
      }, function(instance) {
      });
    }
        let selectedAnnoteEl;
        const selectorForAnnotation = ( cell, annotation) => {
          let cellAttr = 'data-code-cell="' + cell + '"';
          let lineAttr = 'data-code-annotation="' +  annotation + '"';
          const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
          return selector;
        }
        const selectCodeLines = (annoteEl) => {
          const doc = window.document;
          const targetCell = annoteEl.getAttribute("data-target-cell");
          const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
          const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
          const lines = annoteSpan.getAttribute("data-code-lines").split(",");
          const lineIds = lines.map((line) => {
            return targetCell + "-" + line;
          })
          let top = null;
          let height = null;
          let parent = null;
          if (lineIds.length > 0) {
              //compute the position of the single el (top and bottom and make a div)
              const el = window.document.getElementById(lineIds[0]);
              top = el.offsetTop;
              height = el.offsetHeight;
              parent = el.parentElement.parentElement;
            if (lineIds.length > 1) {
              const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
              const bottom = lastEl.offsetTop + lastEl.offsetHeight;
              height = bottom - top;
            }
            if (top !== null && height !== null && parent !== null) {
              // cook up a div (if necessary) and position it 
              let div = window.document.getElementById("code-annotation-line-highlight");
              if (div === null) {
                div = window.document.createElement("div");
                div.setAttribute("id", "code-annotation-line-highlight");
                div.style.position = 'absolute';
                parent.appendChild(div);
              }
              div.style.top = top - 2 + "px";
              div.style.height = height + 4 + "px";
              div.style.left = 0;
              let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
              if (gutterDiv === null) {
                gutterDiv = window.document.createElement("div");
                gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
                gutterDiv.style.position = 'absolute';
                const codeCell = window.document.getElementById(targetCell);
                const gutter = codeCell.querySelector('.code-annotation-gutter');
                gutter.appendChild(gutterDiv);
              }
              gutterDiv.style.top = top - 2 + "px";
              gutterDiv.style.height = height + 4 + "px";
            }
            selectedAnnoteEl = annoteEl;
          }
        };
        const unselectCodeLines = () => {
          const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
          elementsIds.forEach((elId) => {
            const div = window.document.getElementById(elId);
            if (div) {
              div.remove();
            }
          });
          selectedAnnoteEl = undefined;
        };
          // Handle positioning of the toggle
      window.addEventListener(
        "resize",
        throttle(() => {
          elRect = undefined;
          if (selectedAnnoteEl) {
            selectCodeLines(selectedAnnoteEl);
          }
        }, 10)
      );
      function throttle(fn, ms) {
      let throttle = false;
      let timer;
        return (...args) => {
          if(!throttle) { // first call gets through
              fn.apply(this, args);
              throttle = true;
          } else { // all the others get throttled
              if(timer) clearTimeout(timer); // cancel #2
              timer = setTimeout(() => {
                fn.apply(this, args);
                timer = throttle = false;
              }, ms);
          }
        };
      }
        // Attach click handler to the DT
        const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
        for (const annoteDlNode of annoteDls) {
          annoteDlNode.addEventListener('click', (event) => {
            const clickedEl = event.target;
            if (clickedEl !== selectedAnnoteEl) {
              unselectCodeLines();
              const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
              if (activeEl) {
                activeEl.classList.remove('code-annotation-active');
              }
              selectCodeLines(clickedEl);
              clickedEl.classList.add('code-annotation-active');
            } else {
              // Unselect the line
              unselectCodeLines();
              clickedEl.classList.remove('code-annotation-active');
            }
          });
        }
    const findCites = (el) => {
      const parentEl = el.parentElement;
      if (parentEl) {
        const cites = parentEl.dataset.cites;
        if (cites) {
          return {
            el,
            cites: cites.split(' ')
          };
        } else {
          return findCites(el.parentElement)
        }
      } else {
        return undefined;
      }
    };
    var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
    for (var i=0; i<bibliorefs.length; i++) {
      const ref = bibliorefs[i];
      const citeInfo = findCites(ref);
      if (citeInfo) {
        tippyHover(citeInfo.el, function() {
          var popup = window.document.createElement('div');
          citeInfo.cites.forEach(function(cite) {
            var citeDiv = window.document.createElement('div');
            citeDiv.classList.add('hanging-indent');
            citeDiv.classList.add('csl-entry');
            var biblioDiv = window.document.getElementById('ref-' + cite);
            if (biblioDiv) {
              citeDiv.innerHTML = biblioDiv.innerHTML;
            }
            popup.appendChild(citeDiv);
          });
          return popup.innerHTML;
        });
      }
    }
  });
  </script>
</div> <!-- /content -->
<footer class="footer">
  <div class="nav-footer">
    <div class="nav-footer-left">
      &nbsp;
    </div>   
    <div class="nav-footer-center">
<p>Bu websayfasÄ± <strong>Prof.&nbsp;Dr.&nbsp;Ali GÃ¼ner</strong> tarafÄ±ndan hazÄ±rlanmÄ±ÅŸtÄ±r. Sayfa iÃ§eriÄŸi sadece bilgilendirme amaÃ§lÄ±dÄ±r, tanÄ± ve tedavi iÃ§in mutlaka doktorunuza baÅŸvurunuz.</p>
</div>
    <div class="nav-footer-right">
      &nbsp;
    </div>
  </div>
</footer>




<script src="../../../site_libs/quarto-html/zenscroll-min.js"></script>
</body></html>